20/01/2026
Mounjaro (tirzepatide) is a prescription injection for adults with type 2 diabetes to improve blood sugar control and for weight management, used with diet and exercise; it’s a dual GIP and GLP-1 receptor agonist that boosts insulin, reduces appetite, and slows stomach emptying, leading to significant weight loss and better glycemic control, with common side effects like nausea, diarrhea, and vomiting, and available as prefilled pens for once-weekly subcutaneous injection.
